Cipla

INDIA

180

Total Medicines

135

Active

Dosage Forms

Countries

Tanzania (58) Zambia (43) Ghana (22) Rwanda (21) Zimbabwe (14) Botswana (13) Kenya (9)

Registration Status

Registered 135

3 months to expiry 12

Valid 10

PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) 9

Unknown 6

PRESCRIPTION PREPARATIONS 10TH SCHEDULE, (P.P.10) 4

Suspended 2

PHARMACIST INITIATED MEDICINES, (P.I.M.) 1

Withdrawn 1

Dosage Forms

Tablets 24 TABLET, COATED; ORAL 12 Tablet Uncoated 11 TABLETS 7 Film Coated Tablet 7 Capsules 7 Syrup 6 Inhalation aerosol 5

Local Agents / Applicants

Cipla Limited 55

Cipla Ltd 40

CIPLA LTD 17

Worldwide Healthcare... 14

CIPLA MEDPRO Parc du Cap... 13

CIPLA LIMITED 7

Distributing Wholesalers

Licensed wholesalers / distributors that carry this MAH's brands.

Eastleigh Pharmaceutical

Eastleigh, Nairobi

12 SKUs

Generics Africa

Nairobi

3 SKUs

Browse all wholesalers

Registered Medicines

Showing 20 of 180 · Page 3 of 9

Search all

Product	Form / Strength	Country	Reg. Number	Status
DARUNAVIR-400 Darunavir Ethanolate	- 400 mg	Rwanda	Rwanda FDA-HMP-MA-0085	Registered
DOLUTEGRAVIR (AS SODIUM), LAMIVUDINE, TENOFOVIR DISOPROXIL Dolutegravir (As Sodium), Lamivudine, Tenofovir Disoproxil Fumarate	Film Coated Tablet 50 mg, 300 mg, 300 mg	Rwanda	Rwanda FDA-HMP-MA-0048	Registered
DOLUTEGRAVIR 50 MG FILM-COATED TABLETS Dolutegravir (as dolutegravir sodium) 50 mg	Film-coated tablets 50 mg	Rwanda	Rwanda FDA-HMP-MA-0619	Registered
DOLUTEGRAVIR AND LAMIVUDINE DOLUTEGRAVIR AND LAMIVUDINE 50/300 mg	Tablets 50/300 mg	Tanzania	TAN 21 HM 0474	Registered/Compliant
DOLUTEGRAVIR AND LAMIVUDINE TABLETS DOLUTEGRAVIR AND LAMIVUDINE	TABLETS 50 mg/ 300 mg	Rwanda	Rwanda FDA-HMP-MA-2236	Registered
DOLUTEGRAVIR/LAMIVUDUNE/TENOFOVIR DISOPROXIL FUMARATE TABLETS (Each tablet contains Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate 50mg/300mg/300mg) Dolutegravir/Lamivudine/Tenofovir Disoproxil Fumarate	Dolutegravir/Lamivudine/Tenofovir Disoproxil Fumarate 500mg/300mg/300mg	Ghana	FDA/GD.243-010003	3 months to expiry
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE	TABLET, COATED; ORAL 50; 300; 300MG	Zimbabwe	2019/7.13/5910	PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
DUOVIR Lamivudine and Zidovudine 150 /300mg	Film-coated tablets 150 /300mg	Rwanda	Rwanda FDA-HMP-MA-0255	Registered
Dolutegravir 50mg tablets Dolutegravir Sodium 50 mg	Tablets 50	Tanzania	TZ 18 H 0094	Registered/Compliant
Dolutegravir Lamivudine Tenofovir disoproxil fumarate 50/300/300 mg tablet Dolutegravir Sodium 52.620 mg,Lamivudine 300.000 mg,Tenofovir Disoproxil Fumerate 300.000 mg	Film-coated Tablets 300.000 mg,52.620 mg	Zambia	ZAMRA-HM-26-23	Registered/Compliant
Dolutegravir Tablets 50mg Dolutegravir Sodium 50 mg	Tablet Uncoated 50 mg	Zambia	099/239	Registered/Compliant
Dolutegravir sodium, Lamivudine and tenofovir disoproxil fumarate tablets Dolutegravir sodium, Lamivudine and Tenofovir Disoproxil Fumarate 50/300/300 mg Tablets.	Tablets+ Filmcoated	Zambia	ZAMRA-HM-25-340	Registered/Compliant
Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate Tablets Croscarmellose Sodium (Ac-Di-Sol) 10.000 mg/6 mL,Croscarmellose Sodium (Ac-Di-Sol) 22.000 mg/6 mL,Dolutegravir Sodium 50 mg/6 mL,Insta Moistshield Aqua II A22G21202 Blue 30.000 mg/6 mL,Lamivudine 300 mg/6 mL,Magnesium Stearate (Vegetable Grade) 15.000 mg/6 mL,Magnesium Stearate (Vegetable Grade) 3.000 mg/6 mL,Mannitol (Pearlitol 50 C) 145.000 mg/6 mL,Microcrystalline Cellulose (Avicel PH 101) 45.000 mg/6 mL,Microcrystalline Cellulose (Avicel PH 101) 67.380 mg/6 mL,Microcrystalline Cellulose (Avicel PH 112) 205.000 mg/6 mL,Povidone (PVPK-30) 15.000 mg/6 mL,Purified Water. q.s q.s,Sodium Starch glycolate (Primojel) 20.000 mg/6 mL,Tenofovir Disoproxil Fumarate 300 mg/6 mL	Film Coated Tablet 50/300/300	Tanzania	TAN 24 HM 0056	Registered/Compliant
Dolutegravir/Lamivudine/Tenofovir Disoproxil Fumarate Dolutegravir Sodium 50 mg,Lamivudine 300 mg,Tenofovir Disoproxil Fumarate 300 mg	Tablets	Tanzania	TZ 19 H 0372	Registered/Compliant
EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE Empagliflozin 5mg/ Metformin Hydrochloride 1000mg	Film Coated Tablets 5mg/ 1000mg	Rwanda	Rwanda FDA-HMP-MA-1437	Registered
EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE Empagliflozin 25mg/ Metformin Hydrochloride 1000mg	Film Coated Tablets 25mg/ 1000mg	Rwanda	Rwanda FDA-HMP-MA-1438	Registered
EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE EXTENDED RELEASE TABLETS 12.5 MG/1000 MG Empagliflozin 12.5mg and Metformin Hydrochloride 1000mg	Extended Release Tablets 12.5mg, 1000 mg	Rwanda	Rwanda FDA-HMP-MA-1317	Registered
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	TABLET, COATED; ORAL 5; 1000MG	Zimbabwe	2021/17.7/6070	PRESCRIPTION PREPARATIONS 10TH SCHEDULE, (P.P.10)
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	TABLET, COATED; ORAL 10; 1000MG	Zimbabwe	2021/17.7/6071	PRESCRIPTION PREPARATIONS 10TH SCHEDULE, (P.P.10)
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE	TABLET, COATED; ORAL 12.5; 1000MG	Zimbabwe	2021/17.7/6072	PRESCRIPTION PREPARATIONS 10TH SCHEDULE, (P.P.10)

Prev 1 2 3 4 5 ... 9 Next

180 products